keyword
https://read.qxmd.com/read/38629353/the-association-between-use-of-renin-angiotensin-aldosterone-system-inhibitors-and-the-risk-and-mortality-of-pancreatic-cancer-a-systematic-review-and-meta-analysis
#21
Rasoul Rahimi, Seyed Mahmood Reza Hashemi Rafsanjani, Saeid Heidari-Soureshjani, Catherine Mt Sherwin, Karamali Kasiri
BACKGROUND: Pancreatic Cancer (PC) is one of the most malignant tumors and highly invasive neoplasms around the world. OBJECTIVE: This systematic review and meta-analysis aims to study the relationship between the use of renin-angiotensin-aldosterone system inhibitors and the incidence and mortality of PC. METHODS: The electronic search was conducted systematically until October 10, 2023. in databases, including Scopus, Web of Science (WOS), PubMed/MEDLINE, Cochrane Library, and Embase...
April 16, 2024: Curr Rev Clin Exp Pharmacol
https://read.qxmd.com/read/38629308/current-status-of-preoperative-endoscopic-biliary-drainage-for-distal-and-hilar-biliary-obstruction
#22
REVIEW
Hirotoshi Ishiwatari, Junya Sato, Hiroki Sakamoto, Takuya Doi, Hiroyuki Ono
The purpose of preoperative biliary drainage (PBD) is to reduce complications during the perioperative period. The extrahepatic bile duct comprises distal and hilar bile ducts and assessing the need for PBD must be considered separately for each duct, as surgical procedures and morbidities vary. The representative disease-causing distal bile duct obstruction is pancreatic cancer. A randomized controlled trial has revealed that PBD carries the risk of recurrent cholangitis and pancreatitis before surgery, thus eliminating the need for PBD when early surgery is feasible...
April 17, 2024: Digestive Endoscopy: Official Journal of the Japan Gastroenterological Endoscopy Society
https://read.qxmd.com/read/38629149/mif-nr3c2-axis-regulates-glucose-metabolism-reprogramming-in-pancreatic-cancer-through-mapk-erk-and-ap-1-pathways
#23
JOURNAL ARTICLE
Shouhui Yang, Wei Tang, Azadeh Azizian, Jochen Gaedcke, Yuuki Ohara, Helen Cawley, Nader Hanna, B Michael Ghadimi, Trisha Lal, Subrata Sen, Chad J Creighton, Jianjun Gao, Nagireddy Putluri, Stefan Ambs, S Perwez Hussain
Inflammation and aberrant cellular metabolism are widely recognized as hallmarks of cancer. In pancreatic ductal adenocarcinoma (PDAC), inflammatory signaling and metabolic reprogramming are tightly interwoven, playing pivotal roles in the pathogenesis and progression of the disease. However, the regulatory functions of inflammatory mediators in metabolic reprogramming in pancreatic cancer have not been fully explored. Earlier, we demonstrated that pro-inflammatory mediator macrophage migration inhibitory factor (MIF) enhances disease progression by inhibiting its downstream transcriptional factor nuclear receptor subfamily 3 group C member 2 (NR3C2)...
April 17, 2024: Carcinogenesis
https://read.qxmd.com/read/38628892/characterization-and-evaluation-of-nano-niosomes-encapsulating-docetaxel-against-human-breast-pancreatic-and-pulmonary-adenocarcinoma-cancer-cell-lines
#24
JOURNAL ARTICLE
Mohammadreza Ajdari, Aliyeh Ranjbar, Khashayar Karimian, Maryam Karimi, Hossein Heli, Naghmeh Sattarahmady
BACKGROUND: Docetaxel (DXL) is an antineoplastic agent for cancer treatment, the therapeutic efficiency of which is limited due to low solubility, hydrophobicity, and tissue specificity. OBJECTIVE: In this study, nano-niosomes were introduced for improving therapeutic index of DXL. MATERIAL AND METHODS: In this experimental study, two nano-niosomes were synthesized using Span 20® and Span 80® and a thin film hydration method with DXL loading (DXL-Span20 and DXL-Span80)...
April 2024: Journal of Biomedical Physics & Engineering
https://read.qxmd.com/read/38628808/two-cases-of-a-portal-annular-pancreas-in-patients-undergoing-pancreaticoduodenectomy
#25
Mineto Ohta, Keisuke Fukushima, Hiroyasu Nishimaki, Takayuki Morita, Yuta Ito, Kenji Namiki
INTRODUCTION: Portal annular pancreas (PAP) is a congenital anomaly resulting from aberrant fusion of the ventral and dorsal pancreatic buds around the portal vein (PV). PAP was classified into three types by Joseph et al., based on the location of the main pancreatic duct around the PV. The presence of PAP is important for the surgical procedure because it is associated with the postoperative pancreatic fistula. There are no standardized surgical procedures of resection and reconstruction for PAP...
2024: Case Reports in Gastroenterology
https://read.qxmd.com/read/38628720/msln-induced-emt-cancer-stem-cell-traits-and-chemotherapy-resistance-of-pancreatic-cancer-cells
#26
JOURNAL ARTICLE
Jili Hu, Jia Wang, Xu Guo, Qing Fan, Xinming Li, Kai Li, Zhuoyin Wang, Shuntao Liang, Buhe Amin, Nengwei Zhang, Chaowen Chen, Bin Zhu
Chemoresistance is one of the main reasons for poor prognosis of pancreatic cancer. The effects of mesothelin (MSLN) on chemoresistance in pancreatic cancer are still unclear. We aim to investigate potential roles of MSLN in chemoresistance and its relationship with proliferation, epithelial-mesenchymal transition (EMT) and cancer stemness of pancreatic cancer cells. Human pancreatic cancer cell lines ASPC-1 and Mia PaCa-2 with high and low expression of MSLN, respectively, were selected. The ASPC-1 with MSLN knockout (KO) and Mia PaCa-2 of MSLN overexpression (OE) were generated...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38628502/feasibility-of-comprehensive-genomic-profiling-using-endoscopic-ultrasound-guided-tissue-acquisition-with-a-22-gauge-franseen-needle
#27
JOURNAL ARTICLE
Kazunaga Ishigaki, Yousuke Nakai, Go Endo, Kohei Kurihara, Kota Ishida, Shuichi Tange, Rintaro Fukuda, Shinya Takaoka, Yurie Tokito, Yukari Suzuki, Hiroki Oyama, Sachiko Kanai, Tatsunori Suzuki, Tatsuya Sato, Ryunosuke Hakuta, Tomotaka Saito, Tsuyoshi Hamada, Naminatsu Takahara, Aya Shinozaki-Ushiku, Mitsuhiro Fujishiro
AIM: Comprehensive genomic profiling (CGP) test for solid tumors is now increasingly utilized in clinical practice, especially in pancreatobiliary cancer, and specimens obtained by endoscopic ultrasound-guided tissue acquisition (EUS-TA) are often submitted for tissue-based CGP test. In this study, we evaluated the feasibility of EUS-TA using a 22-gauge Franseen needle for the CGP test. METHODS: Consecutive patients with solid tumors who underwent EUS-TA using a 22-gauge Franseen needle, and whose tissue samples were pre-checked for suitability for CGP test, were included in this single-center, retrospective analysis...
April 2024:
https://read.qxmd.com/read/38627328/studies-on-treatment-within-the-scope-of-medical-biotechnology-for-pancreatic-diseases
#28
REVIEW
Dilara Aylar, Ayse Karatug Kacar
The pancreas is made of two compartments: the exocrine pancreas, a source of digestive enzymes, and the endocrine islets which produce vital hormones. Distinct diseases could arise in the pancreas such as diabetes, neuroendocrine tumors, pancreatitis, and pancreatic cancers. Various treatment methods are being researched against these diseases. Treatment with recombinant proteins, therapeutic antibodies, vaccination, gene therapy, tissue engineering, and stem cell treatment are treatment methods. Furthermore, biomarkers are important for both treatment and diagnosis...
April 16, 2024: Molecular Biotechnology
https://read.qxmd.com/read/38627104/invited-commentary-for-meta-analysis-of-adjuvant-chemotherapy-versus-no-adjuvant-chemotherapy-for-resected-stage-i-pancreatic-cancer
#29
EDITORIAL
Michael G House
No abstract text is available yet for this article.
April 15, 2024: Surgery
https://read.qxmd.com/read/38627014/acquisition-duration-optimization-using-visual-grading-regression-in-68-ga-fapi-46-pet-imaging-of-oncologic-patients
#30
JOURNAL ARTICLE
Ted Nilsson, Pawel Rasinski, Örjan Smedby, Siri Af Burén, Ernesto Sparrelid, J Matthias Löhr, Thuy A Tran, August Blomgren, Antonios Tzortzakakis, Rimma Axelsson, Maria Holstensson
Fibroblast activation protein is a promising target for oncologic molecular imaging with radiolabeled fibroblast activation protein inhibitors (FAPI) in a large variety of cancers. However, there are yet no published recommendations on how to set up an optimal imaging protocol for FAPI PET/CT. It is important to optimize the acquisition duration and strive toward an acquisition that is sufficiently short while simultaneously providing sufficient image quality to ensure a reliable diagnosis. The aim of this study was to evaluate the feasibility of reducing the acquisition duration of [68 Ga]FAPI-46 imaging while maintaining satisfactory image quality, with certainty that the radiologist's ability to make a clinical diagnosis would not be affected...
April 16, 2024: Journal of Nuclear Medicine Technology
https://read.qxmd.com/read/38626807/the-pancreatic-cancer-early-detection-precede-study-is-a-global-effort-to-drive-early-detection-baseline-imaging-findings-in-high-risk-individuals
#31
JOURNAL ARTICLE
George Zogopoulos, Ido Haimi, Shenin A Sanoba, Jessica N Everett, Yifan Wang, Bryson W Katona, James J Farrell, Aaron J Grossberg, Salvatore Paiella, Kelsey A Klute, Yan Bi, Michael B Wallace, Richard S Kwon, Elena M Stoffel, Raymond C Wadlow, Daniel A Sussman, Nipun B Merchant, Jennifer B Permuth, Talia Golan, Maria Raitses-Gurevich, Andrew M Lowy, Joy Liau, Joanne M Jeter, James M Lindberg, Daniel C Chung, Julie Earl, Teresa A Brentnall, Kasmintan A Schrader, Vivek Kaul, Chenchan Huang, Hersh Chandarana, Caroline Smerdon, John J Graff, Fay Kastrinos, Sonia S Kupfer, Aimee L Lucas, Rosalie C Sears, Randall E Brand, Giovanni Parmigiani, Diane M Simeone
BACKGROUND: Pancreatic adenocarcinoma (PC) is a highly lethal malignancy with a survival rate of only 12%. Surveillance is recommended for high-risk individuals (HRIs), but it is not widely adopted. To address this unmet clinical need and drive early diagnosis research, we established the Pancreatic Cancer Early Detection (PRECEDE) Consortium. METHODS: PRECEDE is a multi-institutional international collaboration that has undertaken an observational prospective cohort study...
April 2024: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/38626523/design-synthesis-and-evaluation-of-a-pyrazolo-3-4-d-pyrimidine-derivative-as-a-novel-and-potent-tgf%C3%AE-1r1-inhibitor
#32
JOURNAL ARTICLE
Yubo Wang, Yulin Liu, Yan Zhang, Zixuan Zhang, Lei Xu, Jiefu Wang, Yijie Yang, Biyu Hu, Yuhong Yao, Mingming Wei, Junfeng Wang, Bencan Tang, Kun Zhang, Shuangwei Liu, Guang Yang
The transforming growth factor β1 (TGFβ1)/SMAD signaling pathway regulates many vital physiological processes. The development of potent inhibitors targeting activin receptor-like kinase 5 (ALK5) would provide potential treatment reagents for various diseases. A significant number of ALK5 inhibitors have been discovered, and they are currently undergoing clinical evaluation at various stages. However, the clinical demands were far from being met. In this study, we utilized an alternative conformation-similarity-based virtual screening (CSVS) combined with a fragment-based drug designing (FBDD) strategy to efficiently discover a potent and active hit with a novel chemical scaffold...
April 12, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38626456/talaromides-a-c-bioactive-cyclic-heptapeptides-from-talaromyces-siglerae-isolated-from-a-marine-sponge
#33
JOURNAL ARTICLE
Youbin Cho, Kyu-Hyung Park, Eunhee Kim, Seungjin Kim, Weihong Wang, Hyukjae Choi, Heonjoong Kang
Three new cyclic heptapeptides, talaromides A-C ( 1 - 3 ), were isolated from cultures produced by the fungus Talaromyces siglerae (Ascomycota), isolated from an unidentified sponge. The structures, featuring an unusual proline-anthranilic moiety, were elucidated by analysis of spectroscopic data and chemical transformations, including the advanced Marfey's method and GITC derivatization. Talaromides A and B inhibited migration activity against PANC-1 human pancreatic cancer cells without significant cytotoxicity...
April 16, 2024: Journal of Natural Products
https://read.qxmd.com/read/38626343/codetection-of-proteins-and-rnas-on-extracellular-vesicles-for-pancreatic-cancer-early-diagnosis
#34
JOURNAL ARTICLE
Jie He, Jiang Long, Chunhui Zhai, Jiasu Xu, Kaiwen Bao, Wenqiong Su, Lai Jiang, Guangxia Shen, Xianting Ding
Tumor-derived extracellular vesicles (EVs) carry tumor-specific proteins and RNAs, thus becoming prevalent targets for early cancer diagnosis. However, low expression of EV cargos and insufficient diagnostic power of individual biomarkers hindered EVs application in clinical practice. Herein, we propose a multiplex Codetection platform of proteins and RNAs (Co-PAR) for EVs. Co-PAR adopted a pair of antibody-DNA probes to recognize the same target protein, which in turn formed a double-stranded DNA. Thus, the target protein could be quantified by detecting the double-stranded DNA via qPCR...
April 16, 2024: Analytical Chemistry
https://read.qxmd.com/read/38626292/bcl2a1-neoepitopes-elicited-cytotoxic-t-lymphocytes-are-a-promising-individualized-immunotherapy-of-pancreatic-cancer
#35
JOURNAL ARTICLE
Shengzhe Lin, Jingwen Hong, Suxin Wu, Chenlu Zhu, Fang Liu, Wansong Lin, Xinran Cai, Yunbin Ye, Yanling Chen
Conventional treatments have shown a limited efficacy for pancreatic cancer, and immunotherapy is an emerging option for treatment of this highly fatal malignancy. Neoantigen is critical to improving the efficacy of tumor-specific immunotherapy. The cancer and peripheral blood specimens from human leukocyte antigen (HLA)-A0201 positive pancreatic cancer patient were subjected to next-generation sequencing and bioinformatics analyses were performed to screen high-affinity and highly stable neoepitopes. The activation of cytotoxic T lymphocytes (CTLs) by the mutBCL2A111-20 neoepitope targeting B-cell lymphoma 2-related protein A1 (BCL2A1) mutant epitope was investigated, and the cytotoxicity of mutBCL2A111-20 neoepitope-specific CTLs to pancreatic cancer cells was evaluated...
April 16, 2024: Journal of Leukocyte Biology
https://read.qxmd.com/read/38625917/activated-nad-biosynthesis-pathway-induces-olaparib-resistance-in-brca1-knockout-pancreatic-cancer-cells
#36
JOURNAL ARTICLE
Yuka Sasaki, Takuma Inouchi, Ryusuke Nakatsuka, Amane Inoue, Mitsuko Masutani, Tadashige Nozaki
PARP inhibitors have been developed as anti-cancer agents based on synthetic lethality in homologous recombination deficient cancer cells. However, resistance to PARP inhibitors such as olaparib remains a problem in clinical use, and the mechanisms of resistance are not fully understood. To investigate mechanisms of PARP inhibitor resistance, we established a BRCA1 knockout clone derived from the pancreatic cancer MIA PaCa-2 cells, which we termed C1 cells, and subsequently isolated an olaparib-resistant C1/OLA cells...
2024: PloS One
https://read.qxmd.com/read/38625602/defining-distal-splenopancreatectomy-by-the-mesopancreas
#37
JOURNAL ARTICLE
S-A Safi, A Alexander, W Neuhuber, L Haeberle, A Rehders, T Luedde, I Esposito, G Fluegen, W T Knoefel
BACKGROUND: The implementation of the pathologic CRM (circumferential resection margin) staging system for pancreatic head ductal adenocarcinomas (hPDAC) resulted in a dramatic increase of R1 resections at the dorsal resection margin, presumably because of the high rate of mesopancreatic fat (MP) infiltration. Therefore, mesopancreatic excision (MPE) during pancreatoduodenectomy has recently been promoted and has demonstrated better local disease control, fueling the discussion of neoadjuvant downsizing regimes in MP + patients...
April 16, 2024: Langenbeck's Archives of Surgery
https://read.qxmd.com/read/38623919/donor-preactivation-based-glycan-assembly-from-manual-to-automated-synthesis
#38
JOURNAL ARTICLE
Wenlong Yao, Xin-Shan Ye
ConspectusCarbohydrates are called the third chain of life. Carbohydrates participate in many important biochemical functions in living species, and the biological information carried by them is several orders of magnitude larger than that of nucleic acids and proteins. However, due to the intrinsic complexity and heterogeneity of carbohydrate structures, furnishing pure and structurally well-defined glycans for functional studies is a formidable task, especially for homogeneous large-size glycans. To address this issue, we have developed a donor preactivation-based one-pot glycosylation strategy enabling multiple sequential glycosylations in a single reaction vessel...
April 15, 2024: Accounts of Chemical Research
https://read.qxmd.com/read/38623754/comprehensive-assessment-of-the-intrinsic-pancreatic-microbiome
#39
JOURNAL ARTICLE
Austin M Eckhoff, Ashley A Fletcher, Matthew S Kelly, Anders Dohlman, Caitlin A McIntyre, Xiling Shen, Matthew K Iyer, Daniel P Nussbaum, Peter J Allen
OBJECTIVE: We sought to comprehensively profile tissue and cyst fluid in patients with benign, precancerous, and cancerous conditions of the pancreas to characterize the intrinsic pancreatic microbiome. SUMMARY BACKGROUND DATA: Small studies in pancreatic ductal adenocarcinoma (PDAC) and intraductal papillary mucinous neoplasm (IPMN) have suggested that intra-pancreatic microbial dysbiosis may drive malignant transformation. METHODS: Pancreatic samples were collected at the time of resection from 109 patients...
April 16, 2024: Annals of Surgery
https://read.qxmd.com/read/38623490/trends-in-mortality-from-gastrointestinal-hepatic-and-pancreatic-cancers-in-the-united-states-a-comprehensive-analysis-1999-2020
#40
JOURNAL ARTICLE
Hassam Ali, Rizwan Ishtiaq, Brandon Tedder, Joshua Zweigle, Romina Nomigolzar, Dushyant S Dahiya, Vishali Moond, Amir Humza Sohail, Pratik Patel, Debargha Basuli, Hans L Tillmann
BACKGROUND AND AIM: This study investigates temporal trends in gastrointestinal cancer-related mortality in the United States between 1999 and 2020, focusing on differences by sex, age, and race. METHODS: We investigated the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research multiple causes of death database (Years 1999-2020) for gastrointestinal cancer-related mortality with a focus on the underlying cause of death. RESULTS: A total of 3 115 243 gastrointestinal cancer-related deaths occurred from 1999 to 2020...
April 2024: JGH Open: An Open Access Journal of Gastroenterology and Hepatology
keyword
keyword
702
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.